由TRPM2-AS/miR-424-5p轴调节的PDIA6通过TGF-β通路促进子宫内膜癌的进展
Pengling Wang1, Tianli Zhang2, Nan Jiang1
1Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Cell death & disease
|December 14, 2023
概括
蛋白二硫化异构酶A6 (PDIA6) 在子宫内膜癌中被上调,促进细胞增殖和转移. 这项研究揭示了PDIA6作为潜在的治疗点,揭示了它在调节TGF-β通路中的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 蛋白二硫化异构酶A6 (PDIA6) 涉及到各种癌症,但其在子宫内膜癌中的具体作用在很大程度上是未知的.
- 子宫内膜癌是一个重大的全球健康问题,需要确定新的治疗点.
研究的目的:
- 阐明PDIA6在子宫内膜癌中的功能和机制.
- 在子宫内膜癌患者中研究PDIA6表达和临床进展之间的相关性.
主要方法:
- 在子宫内膜癌组织中对PDIA6表达的定量分析.
- 在体外实验评估PDIA6对子宫内膜癌细胞增殖和转移的影响.
- 研究涉及TRPM2-AS/miR-424-5p的调控轴及其对PDIA6和TGF-β通路的影响.
主要成果:
- 在子宫内膜癌中,PDIA6的表达显著上调,与晚期疾病相关.
- 过度表达PDIA6增强了子宫内膜癌细胞的增殖和转移能力.
- 通过调节由TRPM2-AS/miR-424-5p轴调节的TGF-β通路,PDIA6促进恶性行为.
结论:
- 在子宫内膜癌中,PDIA6充当瘤基因,驱动恶性进展.
- TRPM2-AS/miR-424-5p/PDIA6/TGF-β通路代表了子宫内膜癌发病的新机制.
- PDIA6成为未来子宫内膜癌治疗的有希望的候选标.
更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.0K
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
1.5K
相关概念视频
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
